Description
Medical Uses of sofosbuvir/velpatasvir/voxilaprevir tablets
In the US, sofosbuvir/velpatasvir/voxilaprevir is indicated for the treatment of adults with chronic hepatitis C virus infection without cirrhosis (liver disease) or with compensated cirrhosis (Child-Pugh A).
In the EU, it is indicated for the treatment of chronic hepatitis C virus infection in people aged twelve years of aged and older and weighing at least 30 kilograms (66 lb).
VOSEVI® (sofosbuvir, velpatasvir, and voxilaprevir) tablets, for oral use Initial U.S. Approval: 2017
See full prescribing information for VOSEVI.
Get Assistance for VOSEVI Import
Need urgent access to VOSEVI? We’re here to help.
- Expert support for documentation & approvals
- Fast-track import coordination
- End-to-end patient assistance
Call Now | Enquire Today | WhatsApp Support Available
Contact Name: Mr. Tarun Garg
Address: 60/4, Yusaf Sarai, Near Indian Oil Corp., New Delhi – 110 016 (India)
Mobile/WhatsApp. 9891296838.
Email: support@southdelhipharma.com, southdelhipharma@gmail.com
NEWS/UPDATES
- Drug information : Sofosbuvir / Velpatasvir / Voxilaprevir
- Hepatitis C Medicines (Mavyret, Zepatier, and Vosevi): Drug Safety Communication – Due to Rare Occurrence of Serious Liver Injury in Some patients with Advanced Liver Disease
- FDA Approves HCV Treatment Vosevi for Previously Treated Patients
Get Access To VOSEVI (sofosbuvir, velpatasvir, and voxilaprevir) In India
In India, access is facilitated through a legally compliant Named Patient Program (NPP), as per guidelines from the Central Drugs Standard Control Organization. This ensures safe and regulated import of the medicine for individual patients. Brand Name “VOSEVI ” or Generic Name “sofosbuvir, velpatasvir, and voxilaprevir” can be imported for personal use under “Named Patient Program” treatment in in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon (Gurugram), Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, Noida, Kanpur, Lucknow, Dehradun, Shimla India.. Contact us at support@southdelhipharma.com, southdelhipharma@gmail.com or call/WhatsApp at +91-9891296838 to get access as per norms.
Note: South Delhi Pharma, act as a facilitation partner and do not manufacture, sell, or distribute pharmaceutical products. All facilitation activities are conducted in accordance with applicable Indian pharmaceutical and trade regulations.


